0001567619-20-016270.txt : 20200901 0001567619-20-016270.hdr.sgml : 20200901 20200901214415 ACCESSION NUMBER: 0001567619-20-016270 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20200901 DATE AS OF CHANGE: 20200901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYOTT DAVID E I CENTRAL INDEX KEY: 0001051578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 201155606 MAIL ADDRESS: STREET 1: C/O ALLERGAN STREET 2: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2020-08-31 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001051578 PYOTT DAVID E I 105 DIGITAL DRIVE NOVATO CA 94949 1 0 0 0 Common Stock 2020-08-31 4 P 0 11900 78.2151 A 29840 D Common Stock 2020-08-31 4 P 0 900 78.8393 A 30740 D The price in column 4 is the weighted average price. The actual purchase price paid ranged from $77.78 to $78.76. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price. The price in column 4 is the weighted average price. The actual purchase price paid ranged from $78.78 to $78.91. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price. /s/ Laura Randall Woodhead, Attorney-in-Fact 2020-09-01